pH-induced variations in the TK1 gene model

Mutat Res Genet Toxicol Environ Mutagen. 2020 Jan;849:503128. doi: 10.1016/j.mrgentox.2019.503128. Epub 2019 Nov 28.

Abstract

A physiological decrease in extracellular pH (pHe) alters the efficiency of DNA repair and increases formation of DNA double-strand breaks (DSBs). Whether this could translate into genetic instability and variations, was investigated using the TK6 cell model, in which positive selection of the TK1 gene loss-of-function mutations can be achieved from resistance to trifluorothymidine. Cell exposure to suboptimal pH (down to 6.9) for 3 weeks resulted in the 100 % frequency of a stronger frameshift mutation that has spread to both TK1 alleles, whereas weaker frameshift mutations within the 3'exon were eliminated during the selection. Suboptimal pHe values were also found to alter the proportion of the TK1 splicing variant expressed as percent spliced in index values and promote selection of truncated exons as well as intron retention. Although recovery at pH 7.4 did not reverse the selected frameshift mutation, reversal of splice variants and exon truncation towards control values were observed. Hence, suboptimal pHe can induce a combination of mutational events and splicing alterations within the same gene in the resistant clones. This model of positive selection for loss-of-function clearly demonstrates that suboptimal pHe may confer a similar growth advantage when such instability occurs within tumor suppressor genes.

Keywords: DNA repair; Double-strand breaks; Genetic instability; Mutagenesis; pH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing*
  • Antimetabolites / pharmacology
  • Cell Line, Tumor
  • DNA / genetics
  • DNA / metabolism
  • DNA Breaks, Double-Stranded
  • DNA Repair / drug effects
  • Exons
  • Extracellular Space / chemistry
  • Extracellular Space / metabolism
  • Frameshift Mutation*
  • Humans
  • Hydrogen-Ion Concentration
  • Introns
  • Lymphocytes / cytology
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism*
  • Models, Genetic*
  • Mutagenesis*
  • Thymidine Kinase / genetics*
  • Thymidine Kinase / metabolism
  • Trifluridine / pharmacology

Substances

  • Antimetabolites
  • DNA
  • Thymidine Kinase
  • thymidine kinase 1
  • Trifluridine